Gold chosen by PPD for product development in neuroscience

Neurologist and psychiatrist Michael Gold has joined PPD’s neuroscience team as vice president of global product development, the Wilmington-based company announced recently.He will strengthen the company’s ability to “help biopharmaceutical clients manage the complex world of nervous system disorders and deliver therapies more efficiently and cost-effectively,” according to a news release. “Mike’s broad experience in the development of new medicines spans a variety of neurologic conditions, and his expertise in the field of neurodegenerative diseases, including Alzheimer’s and other forms of dementia, is of great value to our clients, as we work together to advance treatment options for these debilitating diseases,” Rob Dow, PPD’s senior vice president, global product development, said in the release. PPD has successfully managed about 285 trials in psychiatry, neurology, pain and ophthalmology indications across all…


Link to Full Article: Gold chosen by PPD for product development in neuroscience